HR 1346 116th Congress House Health Advisory bodies Congressional oversight Department of Health and Human Services Executive agency funding and structure Government information and archives Government studies and investigations Government trust funds Health care costs and insurance Health care coverage and access Health care quality Health information and medical records Health programs administration and funding Health promotion and preventive care Income tax credits Inflation and prices Insurance industry and regulation Medicare Prescription drugs Public contracts and procurement

Medicare Buy-In and Health Care Stabilization Act of 2019

Introduced: February 25, 2019 See on congress.gov

Everywhere this bill has been 5 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Dec 10, 2019

Subcommittee Hearings Held.

Feb 26, 2019

Referred to the Subcommittee on Health.

Feb 25, 2019

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Feb 25, 2019

Referred to the Subcommittee on Health.

Feb 25, 2019

Introduced in House

Plain-English summary Congressional Research Service

Medicare Buy-In and Health Care Stabilization Act of 2019

This bill establishes a Medicare buy-in option for certain qualifying individuals and makes a series of other changes relating to health care costs.

Specifically, the bill allows individuals aged 50 to 64 to enroll in Medicare if such individuals would otherwise qualify for Medicare at the age of 65. The Centers for Medicare & Medicaid Services (CMS) must determine enrollment periods and set premiums for the buy-in option established under the bill, in accordance with specified requirements. The CMS must also award grants to states and nonprofit organizations for outreach and enrollment activities relating to the buy-in option.

The bill also (1) establishes a supplemental option under Medicare to cover cost-sharing for beneficiaries; (2) repeals provisions that prohibit the CMS from negotiating the prices of prescription drugs; and (3) establishes an individual market reinsurance program relating to coverage of high-cost individuals, as specified.

What's happening now December 10, 2019

Subcommittee Hearings Held.

Committees of jurisdiction 4

Energy and Commerce Committee
House of Representatives
Health Subcommittee
House of Representatives · subcommittee of Ways and Means Committee
Health Subcommittee
House of Representatives · subcommittee of Energy and Commerce Committee
Ways and Means Committee
House of Representatives